American Heart Journal
Volume 152, Issue 1 , Pages 102-109 , July 2006

Ischemic stroke after heart failure: A community-based study

  • Brandi J. Witt, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN
    • ,
  • Robert D. Brown Jr, MD, MPH

      Affiliations

    • Department of Neurology, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN
    • ,
  • Steven J. Jacobsen, MD, PhD

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN
    • ,
  • Susan A. Weston, MS

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN
    • ,
  • Karla V. Ballman, PhD

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN
    • ,
  • Ryan A. Meverden, BS

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN
    • ,
  • Véronique L. Roger, MD, MPH

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN
    • Division of Epidemiology, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN
    • Corresponding Author InformationReprint requests: Véronique L. Roger, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Received 6 May 2005 ,Accepted 13 October 2005.

References 

  1. Hellermann JP, Jacobsen SJ, Weston SA, et al. Is the incidence of heart failure changing over time?. Circulation. 2002;19(Suppl):751
  2. Bates BE, Stineman MG. Outcome indicators for stroke: application of an algorithm treatment across the continuum of postacute rehabilitation services. Arch Phys Med Rehabil. 2000;81:1468–1478
  3. Rundek T, Mast H, Hartmann A, et al. Predictors of resource use after acute hospitalization: the Northern Manhattan Stroke Study. Neurology. 2000;55:1180–1187
  4. Marini C, Baldassarre M, Russo T, et al. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology. 2004;62:77–81
  5. Williams J, Bristow M, Fowler M, et al. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376–1398
  6. Fuster V, Gersh B, Giuliani E, et al. The natural history of dilated cardiomyopathy. Am J Cardiol. 1981;47:525–531
  7. Ciaccheri M, Castelli G, Cecchi F, et al. Lack or correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. Br Heart J. 1989;62:26–29
  8. Gottdiener J, Gay J, VanVoorhees L, et al. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. Am J Cardiol. 1983;52:1281–1285
  9. Blondheim D, Jacobs L, Kotler M, et al. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J. 1991;122:763–771
  10. Falk R, Foster E, Coats M. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J. 1992;123:136–142
  11. Kalaria V, Passannante M, Shah T, et al. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am Heart J. 1998;135:215–220
  12. Kyrle P, Korninger C, Gossinger H, et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost. 1985;54:521–523
  13. Natterson P, Stevenson W, Saxon L, et al. Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J. 1995;129:564–570
  14. Loh E, Sutton M, Wun C, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251–257
  15. Dries D, Rosenberg Y, Waclawiw M, et al. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol. 1997;29:1074–1080
  16. Dunkman W, Johnson G, Carson P, et al. Incidence of thromboembolic events in congestive heart failure. Circulation. 1993;87(Suppl VI):VI 94–VI 101
  17. CONSENSUS TSG . Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429–1435
  18. SOLVD i . Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302
  19. AIRE SI . Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821–828
  20. Andersson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J. 1993;126:632–640
  21. Gottdiener J, McClelland R, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular function. Ann Intern Med. 2002;137:631–639
  22. Jelinek M, Ansari M. Congestive heart failure (CCF) as a cause of fatal stroke and all cause death. Aust NZ J Med. 1998;28:799–804
  23. Cioffi G, Pozzoli M, Forni G, et al. Systemic thromboembolism in chronic heart failure. Eur Heart J. 1996;17:1381–1389
  24. Katz S, Marantz P, Biasucci L, et al. Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Am Heart J. 1993;126:141–146
  25. Sharma N, McCullough P, Philbin E, et al. Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest. 2000;117:314–320
  26. Senni M, Triboulloy C, Rodeheffer R, et al. Congestive heart failure in the community. Arch Intern Med. 1999;159:29–34
  27. Thom T, Haase N, Kosamond W, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–e151
  28. Al-Khadra A, Salem D, Rand W, et al. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol. 1998;31:749–753
  29. Walsh M, Prystowsky E. Anti-thrombotic strategies for patients with atrial fibrillation and heart failure. Heart Fail Rev. 2002;7:261–266
  30. Kannel W, Wolf P, Verter J. Manifestations of coronary disease predisposing to stroke: The Framingham Study. JAMA. 1983;250:2942–2946
  31. Gardin J, McClelland R, Kitzman D, et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (The Cardiovascular Health Study). Am J Cardiol. 2001;87:1051–1057
  32. Benjamin E, D'Agostino R, Belanger A, et al. Left atrial size and the risk of stroke and death. Circulation. 1995;92:835–841
  33. Pullicino P, Halperin J, Thompson J. Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology. 2000;54:288–294
  34. Melton L. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;3:266–274
  35. Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  36. Whisnant JP, Melton LJI, Davis PH, et al. Comparison of case ascertainment by medical record linkage and cohort follow-up to determine incidence rates for transient ischemic attacks and stroke. J Clin Epidemiol. 1990;43:791–797
  37. Pitt B, Poole-Wilson P, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial—the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582–1587
  38. Sacco R. Pathogenesis, classification, and epidemiology of cerebrovascular disease. In:  Lewis L editors. Merritt's neurology. 10th ed.. Philadelphia: Lippincott, Williams, and Wilkins; 2000;
  39. Tousoulis D, Charakida M, Stefanadis C. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure. Int J Cardiol. 2005;100:347–353
  40. Di Napoli M, Papa F. Inflammation, blood pressure, and stroke: an opportunity to target primary prevention?. Curr Hypertens Rep. 2005;7:44–51
  41. Ingelsson E, Arnlov J, Sundstrom J, et al. Inflammation, as measured by the erythrocyte sedimentation rate, is an independent predictor for the development of heart failure. J Am Coll Cardiol. 2005;45:1802–1806
  42. Graham S. To anticoagulate or not to anticoagulate patients with dilated cardiomyopathy. Cardiol Clin. 2001;19:605–615
  43. Wilensky R, Jung S. Thromboembolism in patients with decreased left ventricular function: incidence, risk, and treatment. J Cardiovasc Risk. 1995;2:91–96
  44. Lip G, Gibbs C. Does heart failure confer a hypercoagulable state? Virchow's Triad revisited. J Am Coll Cardiol. 1999;33:1424–1426
  45. Lorenzo FD, Newberry D, Scully M, et al. Low molecular weight heparin (bemiparin sodium) and the coagulation profile of patients with heart failure. Am Heart J. 2002;143:e3
  46. Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med. 2004;351:1097–1105
  47. Roger V, Weston S, Redfield M, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344–350
  48. Schellenbaum G, Rea T, Heckbert S, et al. Survival associated with two sets of diagnostic criteria for congestive heart failure. Am J Epidemiol. 2004;160:628–635
  49. Maisel W, Stevenson L. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(Suppl):2D–8D
  50. Luthi J, Flanders W, Pitt S, et al. Outcomes and the quality of care for patients hospitalized for heart failure. Int J Qual Health Care. 2004;16:201–210
  51. Lafata J, Pladevall M, Divine G, et al. Are there race/ethnicity differences in outpatient congestive heart failure management, hospital use, and mortality among an insured population?. Med Care. 2004;42:680–689
  52. Gladowski P, Fetterolf D, Beals S, et al. Analysis of a large cohort of health maintenance organization patients with congestive heart failure. Am J Med Qual. 2003;18:73–81
  53. Scott I, Denaro C, Flores J, et al. Quality of care of patients hospitalized with congestive heart failure. Intern Med J. 2003;33:140–151
  54. Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107–115

 This study was supported in part by grants from the Public Health Service, National Institutes of Health, Bethesda, MD, (AR30582 and HL59205).

PII: S0002-8703(05)00979-8

doi: 10.1016/j.ahj.2005.10.018

American Heart Journal
Volume 152, Issue 1 , Pages 102-109 , July 2006

Article Tools

* Image Usage & Resolution